Table 1

Table.  Drugs for Multiple Myeloma

 

 

Product

 

Class

 

Target

 

Clinical Stage

 

Manufacturer

Genasense

(Oblimersen sodium)

 

Antisense

 

Bcl-2

 

Phase III

 

 

Aventis and Genta

 

Panzem

 

Antiangiogenic

 

Microtubule

Phase II

 

EntreMed

 

SGN-40

 

Antibody

 

CD40

 

Phase I

 

Seattle Genetics

 

Velcade

 

Small molecule

 

Proteasome

 

Market

 

Millennium